Carvana’s Q4 profitability loses traction; shares crater. DoorDash sees double-digit growth in orders, GOV; sets Q1 guidance. Moderna gains as FDA backtracks and accepts flu shot for review.
Wall Street Breakfast Podcast: Carvana Drops Despite Higher Sales
view original post